Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BAXTER INTERNATIONAL INCBAX · Entity 1707 | Director | May 06, 2025 | May 08, 2025 |
| ORACLE CORPORCL · Entity 2805 | Director | September 29, 2026 | October 02, 2026 |
| QUEST DIAGNOSTICS INCDGX · Entity 2118 | Director | March 06, 2023 | March 08, 2023 |
| TENET HEALTHCARE CORPTHC · Entity 2563 | Director | May 22, 2025 | May 28, 2025 |
| XEROX CORPXRX · Entity 12016 | Director | January 12, 2018 | January 16, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BAXTER INTERNATIONAL INC
Report date May 06, 2025 · Filed May 08, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $1 par valueSEC Table I · non-derivative | Direct | 16,499 |
Reported balance
After 2025-05-06 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-05-06 · Grant · Acquired 7,183 · Balance 16,499 F1: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant. F2: Total includes the automatic reinvestment of dividends. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.
F2: Total includes the automatic reinvestment of dividends.
ORACLE CORP
Report date September 29, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy The Stephen H. Rusckowski Living Trust | 25,390 |
Reported balance
After 2026-09-29 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-09-29 · Purchase · Acquired 25,000 · Balance 25,390 F1: This transaction was executed in multiple trades at prices ranging from $138.96 to $139.74. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. |
| Common StockSEC Table I · non-derivative | Direct | 60 |
Reported balance
Holding disclosure · report date 2026-09-29 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 60 |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $138.96 to $139.74. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
QUEST DIAGNOSTICS INC
Report date March 06, 2023 · Filed March 08, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 389,597 |
Last balance in matching sequence
After 2023-03-06 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2023-03-06 · Grant · Acquired 82,631 · Balance 428,201 F1: Represents an award of restricted share units granted on February 25, 2013. F2: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2020, approved in accordance with the requirements of Rule 16b-3(d). Row 2 · 2023-03-06 · Tax withholding · Disposed 38,604 · Balance 389,597 F1: Represents an award of restricted share units granted on February 25, 2013. F3: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted share units granted on February 25, 2013.
F2: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2020, approved in accordance with the requirements of Rule 16b-3(d).
F3: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award.
TENET HEALTHCARE CORP
Report date May 22, 2025 · Filed May 28, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,233 |
Reported balance
After 2025-05-23 transaction · row 1
1 source rowRow 1 · 2025-05-23 · Exercise / conversion · Acquired 1,551 · Balance 5,233 F1: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2026-05-22 | Direct | 1,333 |
Reported balance
After 2025-05-22 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-05-22 · Grant · Acquired 1,333 · Balance 1,333 F2: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2025-05-23 | Direct | 0 |
Reported balance
After 2025-05-23 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-05-23 · Exercise / conversion · Disposed 1,551 · Balance 0 F1: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock.
F2: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares.
XEROX CORP
Report date January 12, 2018 · Filed January 16, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table I · non-derivative | Direct | 17,952 |
Reported balance
After 2018-01-12 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-01-12 · Grant · Acquired 2,793 · Balance 17,952 F1: Each DSU represent the right to receive one share of common stock upon the reporting person's termination of service as a director. F2: This amount includes 103 shares paid on 7/31/17 and 113 shares paid on 10/31/17 from the reinvestment of dividend equivalents paid on Deferred Stock Units held as of 6/30/2017 and 9/29/2017, respectively. |
Filing footnotes · ownership attribution and instrument terms
F1: Each DSU represent the right to receive one share of common stock upon the reporting person's termination of service as a director.
F2: This amount includes 103 shares paid on 7/31/17 and 113 shares paid on 10/31/17 from the reinvestment of dividend equivalents paid on Deferred Stock Units held as of 6/30/2017 and 9/29/2017, respectively.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 29, 2021 Filed Jul 30, 2021 20:16 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 5,300 | $95.80 Strike: $95.80 | $507,713.50 |
DisclosureSEC source: 0001022079-21-000117 · wf-form4_162767612798957.xml · derivative · entry 8 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,193 Underlying: Common Stock · 5,300 shares Expires 2027-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 28, 2021. F5 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 21, 2018, the second on February 21, 2019 and the final on February 21, 2020. Read SEC document |
| July 29, 2021 Filed Jul 30, 2021 20:16 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 4,193 | $141.22 | $592,118.69 |
DisclosureSEC source: 0001022079-21-000117 · wf-form4_162767612798957.xml · nonDerivative · entry 6 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,427 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 28, 2021. F4 · price: This transaction was executed in multiple trades at prices ranging from $141.06 to $141.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 29, 2021 Filed Jul 30, 2021 20:16 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 4,193 | $95.80 | $401,668.44 |
DisclosureSEC source: 0001022079-21-000117 · wf-form4_162767612798957.xml · nonDerivative · entry 5 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,620 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 28, 2021. Read SEC document |
| July 29, 2021 Filed Jul 30, 2021 20:16 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 5,300 | $140.59 | $745,132.30 |
DisclosureSEC source: 0001022079-21-000117 · wf-form4_162767612798957.xml · nonDerivative · entry 4 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,427 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 28, 2021. F3 · price: This transaction was executed in multiple trades at prices ranging from $140.06 to $141.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 29, 2021 Filed Jul 30, 2021 20:16 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 5,300 | $95.80 | $507,713.50 |
DisclosureSEC source: 0001022079-21-000117 · wf-form4_162767612798957.xml · nonDerivative · entry 3 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289,727 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 28, 2021. Read SEC document |
| July 28, 2021 Filed Jul 30, 2021 20:16 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 139,751 | $95.80 Strike: $95.80 | $13,387,447.05 |
DisclosureSEC source: 0001022079-21-000117 · wf-form4_162767612798957.xml · derivative · entry 7 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,493 Underlying: Common Stock · 139,751 shares Expires 2027-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 28, 2021. F5 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 21, 2018, the second on February 21, 2019 and the final on February 21, 2020. Read SEC document |
| July 28, 2021 Filed Jul 30, 2021 20:16 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 139,751 | $140.14 | $19,584,844.89 |
DisclosureSEC source: 0001022079-21-000117 · wf-form4_162767612798957.xml · nonDerivative · entry 2 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,427 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 28, 2021. F2 · price: This transaction was executed in multiple trades at prices ranging from $140.00 to $140.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 28, 2021 Filed Jul 30, 2021 20:16 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 139,751 | $95.80 | $13,387,447.05 |
DisclosureSEC source: 0001022079-21-000117 · wf-form4_162767612798957.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 424,178 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 28, 2021. Read SEC document |
| July 27, 2021 Filed Jul 28, 2021 20:21 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 32,788 | $95.80 Strike: $95.80 | $3,140,926.46 |
DisclosureSEC source: 0001022079-21-000115 · wf-form4_162750365363041.xml · derivative · entry 6 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,244 Underlying: Common Stock · 32,788 shares Expires 2027-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 28, 2021. F3 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 21, 2018, the second on February 21, 2019 and the final on February 21, 2020. Read SEC document |
| July 27, 2021 Filed Jul 28, 2021 20:21 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 32,788 | $140.01 | $4,590,549.52 |
DisclosureSEC source: 0001022079-21-000115 · wf-form4_162750365363041.xml · nonDerivative · entry 4 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,427 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 28, 2021. F2 · price: This transaction was executed in multiple trades at prices ranging from $140.00 to $140.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 27, 2021 Filed Jul 28, 2021 20:21 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 32,788 | $95.80 | $3,140,926.46 |
DisclosureSEC source: 0001022079-21-000115 · wf-form4_162750365363041.xml · nonDerivative · entry 3 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,215 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 28, 2021. Read SEC document |
| July 26, 2021 Filed Jul 28, 2021 20:21 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 5,813 | $95.80 Strike: $95.80 | $556,856.34 |
DisclosureSEC source: 0001022079-21-000115 · wf-form4_162750365363041.xml · derivative · entry 5 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,032 Underlying: Common Stock · 5,813 shares Expires 2027-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 28, 2021. F3 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 21, 2018, the second on February 21, 2019 and the final on February 21, 2020. Read SEC document |
| July 26, 2021 Filed Jul 28, 2021 20:21 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 5,813 | $140.03 | $813,994.39 |
DisclosureSEC source: 0001022079-21-000115 · wf-form4_162750365363041.xml · nonDerivative · entry 2 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,427 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 28, 2021. Read SEC document |
| July 26, 2021 Filed Jul 28, 2021 20:21 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 5,813 | $95.80 | $556,856.34 |
DisclosureSEC source: 0001022079-21-000115 · wf-form4_162750365363041.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 290,240 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 28, 2021. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:33 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 25,887 | $115.42 | $2,987,877.54 |
DisclosureSEC source: 0001022079-21-000060 · wf-form4_161549838956269.xml · nonDerivative · entry 2 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,427 F1 · security: Represents an award of restricted share units granted on February 25, 2013. F3 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:33 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 58,368 | $115.42 | $6,736,834.56 |
DisclosureSEC source: 0001022079-21-000060 · wf-form4_161549838956269.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,314 F1 · security: Represents an award of restricted share units granted on February 25, 2013. F2 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 19, 2018, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| February 24, 2021 Filed Feb 25, 2021 21:31 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 3,319 | $121.19 | $402,229.61 |
DisclosureSEC source: 0001022079-21-000039 · wf-form4_161428867883226.xml · nonDerivative · entry 2 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,946 F2 · security: Represents an award of restricted share units granted on February 25, 2013. F3 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 21:31 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 4,033 | $121.15 | $488,597.95 |
DisclosureSEC source: 0001022079-21-000039 · wf-form4_161428867883226.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,265 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of previous grants of restricted share units. Read SEC document |
| February 17, 2021 Filed Feb 20, 2021 01:47 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 120,901 | $0.00 Strike: $121.81 | $0.00 |
DisclosureSEC source: 0001022079-21-000025 · wf-form4_161378565309991.xml · derivative · entry 2 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,901 Underlying: Common Stock · 120,901 shares Expires 2031-02-17 F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 17, 2021 Filed Feb 20, 2021 01:47 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 21,551 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-21-000025 · wf-form4_161378565309991.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,298 F1 · security: Represents an award of restricted share units. Read SEC document |
| October 16, 2020 Filed Oct 19, 2020 20:17 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 291,997 | $66.51 Strike: $66.51 | $19,420,720.47 |
DisclosureSEC source: 0001022079-20-000175 · wf-form4_160313862410575.xml · derivative · entry 3 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 291,997 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on July 24, 2020. F2 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 25, 2017, the second on February 25, 2018 and the final on February 25, 2019. Read SEC document |
| October 16, 2020 Filed Oct 19, 2020 20:17 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 291,997 | $120.00 | $35,039,640.00 |
DisclosureSEC source: 0001022079-20-000175 · wf-form4_160313862410575.xml · nonDerivative · entry 2 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,747 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on July 24, 2020. Read SEC document |
| October 16, 2020 Filed Oct 19, 2020 20:17 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 291,997 | $66.51 | $19,420,720.47 |
DisclosureSEC source: 0001022079-20-000175 · wf-form4_160313862410575.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 529,744 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on July 24, 2020. Read SEC document |
| April 27, 2020 Filed Apr 28, 2020 20:45 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 11,717 | $71.17 Strike: $71.17 | $833,898.89 |
DisclosureSEC source: 0001022079-20-000103 · wf-form4_158810667839365.xml · derivative · entry 3 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,717 shares Expires 2025-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 4, 2020. F3 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 23, 2016, the second on February 23, 2017 and the final on February 23, 2018. Read SEC document |
| April 27, 2020 Filed Apr 28, 2020 20:45 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 11,717 | $112.01 | $1,312,432.89 |
DisclosureSEC source: 0001022079-20-000103 · wf-form4_158810667839365.xml · nonDerivative · entry 2 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,747 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 4, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $112.00 to $112.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 27, 2020 Filed Apr 28, 2020 20:45 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 11,717 | $71.17 | $833,898.89 |
DisclosureSEC source: 0001022079-20-000103 · wf-form4_158810667839365.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,464 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 4, 2020. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 20:55 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 100 | $71.17 Strike: $71.17 | $7,117.00 |
DisclosureSEC source: 0001022079-20-000071 · wf-form4_158404652569875.xml · derivative · entry 5 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,717 Underlying: Common Stock · 100 shares Expires 2025-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 4, 2020. F4 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 23, 2016, the second on February 23, 2017 and the final on February 23, 2018. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 20:55 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 100 | $112.19 | $11,219.00 |
DisclosureSEC source: 0001022079-20-000071 · wf-form4_158404652569875.xml · nonDerivative · entry 4 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,747 F3 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 4, 2020. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 20:55 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 100 | $71.17 | $7,117.00 |
DisclosureSEC source: 0001022079-20-000071 · wf-form4_158404652569875.xml · nonDerivative · entry 3 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 4, 2020. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 20:55 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 13,898 | $106.46 | $1,479,581.08 |
DisclosureSEC source: 0001022079-20-000071 · wf-form4_158404652569875.xml · nonDerivative · entry 2 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,747 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 20:55 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 25,085 | $106.46 | $2,670,549.10 |
DisclosureSEC source: 0001022079-20-000071 · wf-form4_158404652569875.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,645 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2017, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 06, 2020 Filed Mar 10, 2020 20:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 230,178 | $71.17 Strike: $71.17 | $16,381,768.26 |
DisclosureSEC source: 0001022079-20-000065 · wf-form4_158387269621728.xml · derivative · entry 7 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,817 Underlying: Common Stock · 230,178 shares Expires 2025-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 4, 2020. F7 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 23, 2016, the second on February 23, 2017 and the final on February 23, 2018. Read SEC document |
| March 06, 2020 Filed Mar 10, 2020 20:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 2,000 | $116.27 | $232,544.00 |
DisclosureSEC source: 0001022079-20-000065 · wf-form4_158387269621728.xml · nonDerivative · entry 6 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,560 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 4, 2020. F6 · price: This transaction was executed in multiple trades at prices ranging from $116.05 to $116.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 06, 2020 Filed Mar 10, 2020 20:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 3,937 | $115.45 | $454,534.52 |
DisclosureSEC source: 0001022079-20-000065 · wf-form4_158387269621728.xml · nonDerivative · entry 5 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,560 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 4, 2020. F5 · price: This transaction was executed in multiple trades at prices ranging from $115.05 to $116.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 06, 2020 Filed Mar 10, 2020 20:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 16,426 | $114.24 | $1,876,440.54 |
DisclosureSEC source: 0001022079-20-000065 · wf-form4_158387269621728.xml · nonDerivative · entry 4 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,497 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 4, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $114.03 to $114.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 06, 2020 Filed Mar 10, 2020 20:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 36,790 | $113.65 | $4,181,257.08 |
DisclosureSEC source: 0001022079-20-000065 · wf-form4_158387269621728.xml · nonDerivative · entry 3 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,923 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 4, 2020. F3 · price: This transaction was executed in multiple trades at prices ranging from $113.03 to $114.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 06, 2020 Filed Mar 10, 2020 20:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 171,025 | $112.21 | $19,190,202.18 |
DisclosureSEC source: 0001022079-20-000065 · wf-form4_158387269621728.xml · nonDerivative · entry 2 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,713 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 4, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $112.00 to $112.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 06, 2020 Filed Mar 10, 2020 20:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 230,178 | $71.17 | $16,381,768.26 |
DisclosureSEC source: 0001022079-20-000065 · wf-form4_158387269621728.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 456,738 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 4, 2020. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 00:21 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 4,299 | $112.90 | $485,357.10 |
DisclosureSEC source: 0001022079-20-000056 · wf-form4_158284926106265.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,560 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 21:31 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 2,074 | $113.34 | $235,067.16 |
DisclosureSEC source: 0001022079-20-000045 · wf-form4_158275270122533.xml · nonDerivative · entry 2 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,859 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 21:31 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 2,404 | $112.17 | $269,656.68 |
DisclosureSEC source: 0001022079-20-000045 · wf-form4_158275270122533.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,933 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 18, 2020 Filed Feb 21, 2020 01:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 145,361 | $0.00 Strike: $112.17 | $0.00 |
DisclosureSEC source: 0001022079-20-000032 · wf-form4_158224910608140.xml · derivative · entry 2 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,361 Underlying: Common Stock · 145,361 shares Expires 2030-02-18 F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 18, 2020 Filed Feb 21, 2020 01:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 22,288 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-20-000032 · wf-form4_158224910608140.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,337 F1 · security: Represents an award of restricted share units. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 20:36 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionStock Options (Right to Buy) · Derivative | 244,565 | $52.17 Strike: $52.17 | $12,757,733.23 |
DisclosureSEC source: 0001022079-19-000149 · wf-form4_156080377688911.xml · derivative · entry 3 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 244,565 shares Expires 2024-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options vested in three equal annual installments beginning with the first on February 13, 2015, the second on February 13, 2016 and the final on February 13, 2017. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 20:36 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 244,565 | $100.00 | $24,456,500.00 |
DisclosureSEC source: 0001022079-19-000149 · wf-form4_156080377688911.xml · nonDerivative · entry 2 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,049 Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 20:36 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 244,565 | $52.17 | $12,757,733.23 |
DisclosureSEC source: 0001022079-19-000149 · wf-form4_156080377688911.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 457,614 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 22,698 | $86.86 | $1,971,548.28 |
DisclosureSEC source: 0001022079-19-000094 · wf-form4_155182163358244.xml · nonDerivative · entry 2 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,049 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 38,341 | $86.86 | $3,330,299.26 |
DisclosureSEC source: 0001022079-19-000094 · wf-form4_155182163358244.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,747 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 25, 2016, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:32 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 6,676 | $87.84 | $586,419.84 |
DisclosureSEC source: 0001022079-19-000080 · wf-form4_155139313000306.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,406 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 23:35 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 2,318 | $88.24 | $204,540.32 |
DisclosureSEC source: 0001022079-19-000066 · wf-form4_155131053574827.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,082 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.